Michael Benatar, Donald Sanders. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Anti-Inflammatory Agents/administration & dosageAnti-Inflammatory Agents/therapeutic useBiomarkersHumansImmunosuppressive Agents/therapeutic useInterleukin-2/bloodMyasthenia Gravis/drug therapyPrednisone/administration & dosagePrednisone/therapeutic useRandomized Controlled Trials as TopicResearch DesignTacrolimus/therapeutic use
Substances: See more » Anti-Inflammatory AgentsBiomarkersImmunosuppressive AgentsInterleukin-2PrednisoneTacrolimus
Year: 2011 PMID: 21821871 DOI: 10.1136/jnnp.2011.243931
Source DB: PubMed Journal: J Neurol Neurosurg Psychiatry ISSN: 0022-3050 Impact factor: 10.154